Joyvie Health Raises $1M to Redesign Continence Care

Jan de Vries · 2026-06-05

### A Personal Story Behind a Medical Breakthrough Joyvie Health, a UK-based startup, has closed its pre-Seed funding round at $1.04 million (converted from €897k). The company is rethinking continence underwear from the ground up. Their goal? To cut stool-to-skin contact, keep skin healthy, and lighten the load for caregivers. The funding comes from an Innovate UK grant, plus investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and a handful of angel investors. "Products designed for care should never cause harm," says Zoe Robson, founder and CEO of Joyvie Health. "That's not a vision statement. It's the reason this company exists." ### Why This Matters Right Now 2026 is shaping up to be a big year for health tech in the UK and Europe. Joyvie's round is just one piece of a much bigger puzzle. Here's a snapshot of related funding announcements: - **Semble** raised $37.8 million to scale its healthcare management platform for outpatient providers. - **Evaro** secured $22.9 million to expand NHS-licensed embedded health services. - **JAAQ** closed $16.3 million to grow enterprise partnerships. - **Calibre** emerged from stealth with $3.1 million to tackle health "guesswork." - **Nul** raised $915k to launch its alcohol-dependence care platform. Across Europe, the action is just as intense: - **Recare** in Berlin raised up to $40.3 million for its AI hospital platform. - **Patronus** raised $12 million for a senior-friendly emergency smartwatch and family app. - **Tucuvi** raised $18.5 million to scale voice-AI nursing follow-up automation. - **Ditto** in Rotterdam raised $8.3 million to simplify medical information for patients. - **ShanX Medtech** secured $26.2 million to advance antimicrobial-resistance diagnostics, starting with women's health. - **MedVasc** raised $2.4 million to push its anesthesia catheter toward US approval. All told, that's over $188 million in related health tech funding this year. "At Lavender Ventures, we back founders tackling large, underserved markets with real solutions," says Gail Armstrong of Lavender Ventures. "Joyvie's approach can improve lives for individuals, caregivers, healthcare systems, and the environment."  ### The Heartbreaking Origin Story Joyvie Health was born from loss. Zoe Robson's father, Fred, died in 2025 at age 77. He was fit and sharp-minded until a late-stage pancreatic cancer diagnosis hit on Christmas Eve 2024. Eleven weeks later, he was gone. In those final weeks, Fred lost bowel control and had to wear adult diapers. Faeces trapped against skin breaks it down—moisture, pathogens, and pH imbalance cause damage that never fully heals. His skin broke down. His dignity went with it, change by change. And Ruth, his wife and primary caregiver, carried a burden invisible to the outside world. "My parents didn't deserve that," says Zoe. "They were both at their most vulnerable—and the product meant to help them made it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mom. It wasn't from lack of care. It's a design failure." ### A Smarter Solution for a Silent Problem The company's mission is to end the silent humiliation of fecal incontinence (FI), a condition affecting an estimated 656 million people worldwide. Yet the most common non-invasive solution—diapers and pads—hasn't changed in decades. Where existing products trap feces against the skin, Joyvie's design contains stool in a disposable pouch right after excretion. This cuts skin contact significantly, preserves dignity, and speeds up changes. Early testing shows about a 90% reduction in stool-to-skin contact and roughly 70% faster changes. Fecal incontinence often stems from conditions like diarrhea, constipation, nerve damage, or muscle weakness. But the real problem is the lack of innovation in basic care products. Joyvie is stepping into that gap with a design that puts people first.